News About: Med. Insurance
Korea should redefine optimization of medication costsThe Korean government needs to investigate ever-increasing medication costs as part of efforts to understand their optimization size, according to a local professor.
Professo...
|
Positive list system is still under heated debate
The government is likely to push up with the plan to evaluate the economic effectiveness of conventional medicines based on its own assessment criteria.
In a recent forum on September 19, officials from the Health ...
KRPIA calls for more objective evaluation criteria on medicinesThe Korea Research-based Pharmaceutical Industry Association (KRPIA) reclaimed that health authorities need to establish more transparent and objective guidelines in assessing t...
|
Health ministry to get tough over generic data fabrication
Drug makers who are found to market any generic drugs whose bioequivalence testing was falsified after getting into the national health insurance will be subject to a heavy fine, five times as high as revenues, accord...
Health insurance covers additional indications of Lyrica
Pfizer Korea says the national health insurance has covered the additional indications of anticonvulsant drug Lyrica (pregabalin), such as neuropathic pain after spinal cord injury and complex regional pain syndrome (...
Hospital overcharges W5.8 billion won
Patients will receive about 5.8 billion won in medical fee refunds because some hospitals overcharged for health insurance coverage, health authorities said on September 8.
The Health Insurance Review & Assessment...
Patients to benefit from homegrown Peluvi tablet
The National Health Insurance Corporation and Daewon Pharm finally agreed on September 3 to set the insurance price of Peluvi (felubiprofen) at 208 won per tablet.
Daewon demanded the government set a minimum price...
3,729 items to be re-evaluated over economic effectiveness
The Health Insurance Review and Assess Service (HIRA) announced on September 2 that a total of 3,729 items from six therapeutic categories will be evaluated for their economic effectiveness within this year.
The si...
Government to streamline drug pricing policy
OTC products to be deleted from health insurance eligible category will be carefully selected to prevent “drug shift phenomenon”, according to the Ministry of Health, Welfare and Family Affairs.
In a recent forum, ...
Yungjin, Ildong face redemption suit of medication costs
The National Health Insurance Corporation filed a suit against Yungjin Pharm and Ildong Pharm, for their improper health insurance allowance claim of medicines involved in fabricated bioequivalence test results.
“T...
